Search for: [Abstract = "nd the analyzed antibodies. In the APS patients \(women, 75%, mean disease duration, 7 years\) positive correlations between anti\-Nε\-Hcy\-albumin and \-hemoglobin antibodies and ACL IgG levels \(r=0.75, p<0.0001 i r=0.73, p<0.0001\) and concentrations of anti\-β2GPI antibodies \(r=0.46, p=0.004 i r=0.47, p=0.003\) were found. Higher levels of anti\-Nε\-Hcy\-albumin \(0.481 \[0.344\-0.669\] vs 0.363 \[0.237\-0.540\], p=0.048\) and \-hemoglobin antibodies \(0.591 \[0.441\-0.791\] vs 0.468 \[0.341\-0.667\], p=0.046\) were found in subjects with lupus anticoagulant \(LA\) compared to the remaining APS patients. In APS patients there were also positive correlations between anti\-Nε\-Hcy\-protein antibodies and CRP concentrations. No associations were found between anti\-Nε\-Hcy\-proteins antibodies and clinical manifestations, treatment and the age of the APS patients. There were correlations only between tHcy concentrations and levels of both anti\- Nε\-Hcy\-albumin \(r=0.61, p<0.0001\) and \-hemoglobin antibodies \(r=0.59, p<0.0001\) in healthy subjects. Similarly to the results in the patients, control subjects with the TT genotype had significantly higher levels of anti\-Nε\-Hcy\-albumin and \-hemoglobin antibodies compared to those with CC\- and CT\-genotype. By the linear regression analysis, performed in a whole group of 130 patients, tHcy and CRP concentrations were independent predictors of level of anti\-N"]

Number of results: 1